SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC

Clinical trial NCT05652192 · RECRUITING

Trial details

NCT number: NCT05652192
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Nasopharyngeal Carcinoma

Start date: 2022-09-15
Primary completion: 2026-10-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.